Analyst Ratings for Compass Therapeutics (CMPX)
CMPX Rating Summary
CMPX Price Target Summary
- Highest: $12.00 (H.C. Wainwright)
- Lowest: $1.00 (Wedbush)
- Average: $6.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$6.00 (+597.7%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
Avg. $ Target:
$6.00 (+597.7%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/22/2026 | Wedbush | Robert Driscoll | Downgrade | Neutral (Outperform) |
1.00 (N/A) |
1.82 (0.86) |
-52.75% | Details |
| 7/21/2026 | Leerink | Asthika Goonewardene | New Coverage | Outperform (N/A) |
4.00 (N/A) |
2.02 (0.86) |
-57.43% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
